Inflammation and behavioral symptoms after breast cancer treatment: do fatigue, depression, and sleep disturbance share a common underlying mechanism?
|Title||Inflammation and behavioral symptoms after breast cancer treatment: do fatigue, depression, and sleep disturbance share a common underlying mechanism?|
|Publication Type||Journal Article|
|Year of Publication||2011|
|Authors||Bower, JE, Ganz PA, Irwin MR, Kwan L, Breen EC, Cole SW|
|Journal||Journal of clinical oncology : official journal of the American Society of Clinical Oncology|
|Date Published||2011 Sep 10|
|Keywords||Adult, Aged, Antineoplastic Agents, Biological Markers, Breast Neoplasms, C-Reactive Protein, California, Combined Modality Therapy, Depression, Fatigue, Female, Humans, Inflammation, Interleukin 1 Receptor Antagonist Protein, Mastectomy, Middle Aged, Multivariate Analysis, Radiotherapy, Receptors, Tumor Necrosis Factor, Type II, Sleep disorders|
Fatigue, depression, and sleep disturbance are common adverse effects of cancer treatment and frequently co-occur. However, the possibility that inflammatory processes may underlie this constellation of symptoms has not been examined.
|Alternate Journal||J. Clin. Oncol.|